Session » Health Services Research Poster

Date: Saturday, November 7, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 0581

A Proposed Economic Framework to Model the Consequences of Psoriatic Arthritis Disease Domains

9:00AM-11:00AM: Abstract Number: 0592

A Rheumatology-Driven Protocol and Treatment Algorithm of SARS-CoV-2 Cytokine Release Syndrome and Its Associated Outcomes

9:00AM-11:00AM: Abstract Number: 0606

A Systematic Review Exploring Pre-COVID-19 Telehealthcare Models Used in the Management of Patients with Rheumatological Disease

9:00AM-11:00AM: Abstract Number: 0590

A Web-Based Data Capture System Can Successfully Collect Detailed and Quantifiable Physical Therapy Intervention Data Post Total Knee Replacement

9:00AM-11:00AM: Abstract Number: 0569

Ability and Willingness to Utilize Telemedicine Among Rheumatology Patients – a Cross Sectional Survey

9:00AM-11:00AM: Abstract Number: 0587

Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic

9:00AM-11:00AM: Abstract Number: 0610

Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak

9:00AM-11:00AM: Abstract Number: 0596

Clinical Academic Rheumatology: A Boon for Health Systems

9:00AM-11:00AM: Abstract Number: 0568

Clinical Timelines and Management Delays in Suspected Giant Cell Arteritis

9:00AM-11:00AM: Abstract Number: 0616

Correlation Between Disease Activity and Perceived Economic Barriers to Care in a Population of African American Women with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 0583

Cost of Illness in Patients with Psoriasis and Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 0585

Cost-effectiveness of Motivational Counselling and SMS-reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0612

Differences in 30-Day Rehospitalization Risk and Predictors by Age Group Among Patients with Lupus in Medicare

9:00AM-11:00AM: Abstract Number: 0611

Disease Activity and Disability Are Not Associated with Rehabilitation Utilization in African Americans with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0620

Do Physical Therapists Follow Evidence-Based Practice Recommendations for Treatment of Inflammatory Arthritides?

9:00AM-11:00AM: Abstract Number: 0573

Effects of Successive Switches of Two Different Biosimilars of Etanercept on Outcomes in Inflammatory Rheumatic Diseases in Daily Practice

9:00AM-11:00AM: Abstract Number: 0599

Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic

9:00AM-11:00AM: Abstract Number: 0588

Feast or Famine? An Institutional Assessment of Hydroxychloroquine Screening Practices

9:00AM-11:00AM: Abstract Number: 0578

Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics

9:00AM-11:00AM: Abstract Number: 0600

Gout Increases Length of Stay in Patients Hospitalized for Heart Failure Exacerbation

9:00AM-11:00AM: Abstract Number: 0595

High Satisfaction with Tele-medicine in a New York City Clinic

9:00AM-11:00AM: Abstract Number: 0605

How Did SARS-CoV2/COVID-19 Pandemic Affected Rheumatology Practice in Latin America? A Regional Survey from PANLAR

9:00AM-11:00AM: Abstract Number: 0598

Impact of a Dedicated Lupus Nephritis Clinic to Improve Time to Biopsy and Care Quality

9:00AM-11:00AM: Abstract Number: 0614

Impact of COVID-19 Pandemic on the Rheumatology Practice in Mexico: Mexican College of Rheumatology Survey

9:00AM-11:00AM: Abstract Number: 0609

Impact of Depressive Symptoms, Anti-depression Treatment on Direct Medical Costs Among Medicare Beneficiaries with Knee Osteoarthritis (KOA)

9:00AM-11:00AM: Abstract Number: 0571

Improving Care for Patients with Inflammatory Arthritis by Enabling Physical Therapists to Directly Refer to Rheumatologists: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 0604

Increasing the Rate of Pneumococcal Vaccination in an Academic Rheumatology Outpatient Clinic

9:00AM-11:00AM: Abstract Number: 0591

Intervention to Improve SLE Medication Adherence Using Surescripts Pharmacy Refill Data

9:00AM-11:00AM: Abstract Number: 0574

Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus

9:00AM-11:00AM: Abstract Number: 0602

Labor Impact of SARS-COV-2 Pandemic in Argentine Rheumatologists

9:00AM-11:00AM: Abstract Number: 0594

Mechanical and Temperature Stress During Biologic Shipments to Rheumatology Patients

9:00AM-11:00AM: Abstract Number: 0576

Medical Savings of Timely Rheumatoid Arthritis Diagnoses

9:00AM-11:00AM: Abstract Number: 0613

Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease

9:00AM-11:00AM: Abstract Number: 0582

Mortality and Cost of Hospitalization: Do Hospitals Caring for More SLE Patients Perform Better?

9:00AM-11:00AM: Abstract Number: 0603

Multisite Study of the Impact of COVID-19 Era Telemedicine Expansion on Reduction in No-Show Rates

9:00AM-11:00AM: Abstract Number: 0608

Patient and Parent Perspectives in a Academic Pediatric Rheumatology Transition Clinic

9:00AM-11:00AM: Abstract Number: 0593

Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA

9:00AM-11:00AM: Abstract Number: 0586

Performance Characteristics of ANA by Elisa and Immunofluorescence

9:00AM-11:00AM: Abstract Number: 0619

Pharmacist Intervention: Reducing Insurance Denials of Specialty Medications

9:00AM-11:00AM: Abstract Number: 0577

Qualitative Review of Unsuccessful Pilot Study of Super-Utilizer Systemic Lupus Erythematosus (SLE) Patients Enrollment into Team Based Program to Improve Patient Outcomes

9:00AM-11:00AM: Abstract Number: 0567

Rheumatologist’s Perception of the Efficacy, Safety and Willingness to Prescribe Infliximab and Use Alternate Drug Supply Programs to Lower Cost of Rheumatoid Arthritis Care

9:00AM-11:00AM: Abstract Number: 0615

Rheumatology Going Digital: Developing a Rheumatology App for Use by All Patients Attending Our Department to Aid Remote Working and Self-management

9:00AM-11:00AM: Abstract Number: 0579

Risk Factors of Nonadherence in New Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 0580

Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting

9:00AM-11:00AM: Abstract Number: 0617

Support Methodologies for African American Women with Lupus – Comparing Two Study’s Effects on Patient Activation

9:00AM-11:00AM: Abstract Number: 0597

Telemedicine in Pediatric Rheumatology During COVID-19: The PR-COIN Experience

9:00AM-11:00AM: Abstract Number: 0601

The “Why” of Drug Discontinuation; Clinical Review of EMR Notes for 2,545 Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 0618

The Effect of Travel Burden on Depression and Anxiety in African American Women Living with Systemic Lupus

9:00AM-11:00AM: Abstract Number: 0607

The Evolution of Rheumatologist’s Practice in Response to the COVID19 Pandemic

9:00AM-11:00AM: Abstract Number: 0589

The Ideal Mhealth Application for Rheumatoid Arthritis: Qualitative Findings from Stakeholder Focus Groups

9:00AM-11:00AM: Abstract Number: 0575

The Impact of an Integrated Care Management Program on Acute Care Utilization and Outpatient Appointment Attendance Among High-Risk Patients with Lupus

9:00AM-11:00AM: Abstract Number: 0570

The Patient Perspective on Using Digital Resources to Address Unmet Needs in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 0584

Total Cost of Care for Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0572

Two-year Cost-effectiveness Between Two Gradual Tapering Strategies in Rheumatoid Arthritis: Cost-utility Analysis of the TARA Trial

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].